Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

LIPI Activators

The term LIPI Activators, referring to activators of lipase I, falls within a specialized category of biochemical compounds. Lipase I, a type of enzyme, plays a critical role in the biochemical process of lipid metabolism, specifically in the hydrolysis of fats into fatty acids and glycerol. Activators of lipase I are therefore compounds that enhance the enzymatic activity of this particular lipase. These activators work by binding to the enzyme, often at specific allosteric sites, thereby inducing a conformational change that increases the enzyme's catalytic efficiency. The molecular structure of these activators is typically characterized by specific functional groups or regions that are complementary to the binding sites on the lipase I enzyme, ensuring a high degree of specificity and efficacy in the activation process.

The development and study of LIPI Activators involve intricate processes in both synthetic chemistry and enzymology. Synthetic chemists design and create a diverse array of compounds, guided by the known structure and active sites of lipase I. This process often involves iterative cycles of synthesis and testing, refining the molecular structure of the activators to achieve optimal interaction with the enzyme. Concurrently, enzymologists and biochemists study the interaction between these activators and lipase I using various biochemical assays. Techniques such as enzyme kinetics analysis are pivotal in understanding how these compounds affect the rate of lipid hydrolysis catalyzed by lipase I. Moreover, structural biology techniques, like X-ray crystallography or NMR spectroscopy, are employed to elucidate the molecular details of the interaction between the activator and the enzyme. This detailed understanding aids in the rational design of more effective LIPI Activators, enhancing our comprehension of enzyme regulation and lipid metabolism at the molecular level.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

A known activator of protein kinase C (PKC) that may enhance the transcription of genes involved in lipid metabolism, potentially including LIPI.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor that may upregulate genes by altering epigenetic marks, potentially affecting LIPI expression.

Fenofibrate

49562-28-9sc-204751
5 g
$41.00
9
(1)

A compound that activates peroxisome proliferator-activated receptor alpha (PPARα), potentially increasing the transcription of lipase-related genes.

WY 14643

50892-23-4sc-203314
50 mg
$136.00
7
(1)

A synthetic PPARα agonist that could induce the expression of genes involved in fatty acid catabolism, including potentially LIPI.

Rosiglitazone

122320-73-4sc-202795
sc-202795A
sc-202795C
sc-202795D
sc-202795B
25 mg
100 mg
500 mg
1 g
5 g
$120.00
$326.00
$634.00
$947.00
$1259.00
38
(1)

A PPARγ agonist that may indirectly influence lipase gene expression through effects on lipid homeostasis.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

A metabolite of vitamin A that can modulate gene expression, potentially affecting LIPI as part of lipid metabolism regulation.

SRT1720

1001645-58-4sc-364624
sc-364624A
5 mg
10 mg
$197.00
$364.00
13
(1)

A Sirt1 activator that could influence the expression of genes related to lipid metabolism, potentially including LIPI.

Adenosine 3′,5′-cyclic monophosphate

60-92-4sc-217584
sc-217584A
sc-217584B
sc-217584C
sc-217584D
sc-217584E
100 mg
250 mg
5 g
10 g
25 g
50 g
$116.00
$179.00
$265.00
$369.00
$629.00
$1150.00
(1)

A secondary messenger that may upregulate genes through PKA signaling, potentially affecting LIPI expression.

Lovastatin

75330-75-5sc-200850
sc-200850A
sc-200850B
5 mg
25 mg
100 mg
$29.00
$90.00
$339.00
12
(1)

An HMG-CoA reductase inhibitor that might indirectly upregulate lipase gene expression due to its role in lipid metabolism.

Pioglitazone

111025-46-8sc-202289
sc-202289A
1 mg
5 mg
$55.00
$125.00
13
(1)

Another PPARγ agonist that could have indirect effects on lipase gene expression, potentially including LIPI.